deutsch    english

Registering

User:
Password:

Not registered yet?
Are you a doctor or a dealer in medical products and would like to receive more detailed information about our products?

Register: here

Support

For further information
and telephone support, you can contact us at:

+49 (0) 71 21 - 36 4 03 - 2 99
info(at)okuvision.de

A+ A++   Print

Okuvision can preserve eyesight

OkuStim is one of the first forms of outpatient treatment for retinitis pigmentosa, whose effectiveness has been proven by clinical studies*. About 20,000 people suffering from retinitis pigmentosa in Germany could profit from this.
It has been proven that the OkuStim therapy can delay the progress of the illness and thus preserve eyesight for a longer period. Its special feature: OkuStim transmits weak electrical impulses to the retina. This electronic stimulus to the retina helps to preserve eyesight for a longer period. Nevertheless, this OkuStim therapy for retinitis pigmentosa is hardly perceptible and as a rule causes no pain.

* Schatz, et al, IOVS June 2011

Please note: Our Product is not for sale in the US.

Products:

The OkuStim system gives retinitis pigmentosa patients the chance to positively influence the course of disease. It is recommended to administer the therapy under medical supervision. The OkuStim system consists of three essential components: the neurostimulator, OkuStim, the frame, OkuSpex and the electrode, OkuEl. Using the OkuStim system is easy and is adapted to the requirements of the individuals affected. OkuStim is equipped with an audio output so that even patients in a very advanced stage of the illness can operate it without difficulties.
More information on the components

Retinitis pigmentosa therapy: The OkuStim system with the neurostimulator, OkuStim, the frame, OkuSpex and the electrode, OkuEl. (click to enlarge)
Retinitis pigmentosa therapy: The OkuStim system with the neurostimulator, OkuStim, the frame, OkuSpex and the electrode, OkuEl. (click to enlarge)

News:

2015/01/14

New information sheet for patients and patient brochure updated

Cover of the new okuvision patient brochure

A fact sheet containing all relevant information concerning OkuStim at a glance is available for...

more >
 
2014/08/15

Okuvision GmbH at EURETINA 2014

Booth of Okuvision GmbH

Okuvision GmbH and Retina Implant AG are together again at the 14th EURETINA Congress in London...

more >
 
2014/06/23

Okuvision GmbH at RETINA INTERNATIONAL 2014

Okuvision GmbH is present on site in this year’s World Congress of Ophthalmology RETINA...

more >